FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


13129 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) est un(e) (attribut) Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Clavulanate potassium gm/ticarcillin disodium gm injection solution vial (product) Product containing clavulanic acid and ticarcillin (medicinal product)
Cleaning of animal penis Cleaning of penis
Clear cell (mesonephroid) neoplasm - category (morphologic abnormality) Clear cell mesonephroid neoplasm
Clear cell sarcoma (except of Kidney M-89643) Clear cell sarcoma
Clemastine 1.34mg tablet (product) Clemastine fumarate 1.34 mg oral tablet
Clemastine 500micrograms/5mL elixir (product) Product containing precisely clemastine fumarate 134 microgram/1 milliliter conventional release oral solution (clinical drug)
Clemastine fumarate 0.67mg/5mL syrup (product) Product containing precisely clemastine fumarate 134 microgram/1 milliliter conventional release oral solution (clinical drug)
Clemastine+phenylpropanolamine 0.5/25mg tablet (product) Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet
Clemastine+phenylpropanolamine 0.5/25mg tablet (product) Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet
Clemmys insculpta Glyptemys insculpta (organism)
Clindamycin 1% topical foam Product containing precisely clindamycin phosphate 10 milligram/1 milliliter conventional release cutaneous foam (clinical drug)
Clindamycin 1.2%/tretinoin 0.025% topical gel (product) Clindamycin phosphate 12 mg/g and tretinoin 250 microgram/g cutaneous gel
Clindamycin 2% cream (product) Product containing precisely clindamycin phosphate 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug)
Clindamycin 75mg/mL oral solution (product) Clindamycin (as clindamycin hydrochloride) 75 mg/mL oral suspension
Clindamycin palmitate hydroc 75 mg/ 5mL suspension (product) Clindamycin (as clindamycin hydrochloride) 75 mg/mL oral suspension
Clindamycin palmitate hydroc 75mg/5mL solution (product) Clindamycin (as clindamycin hydrochloride) 75 mg/mL oral suspension
Clindamycin phosphate 1% solution (product) Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution
Clindamycin phosphate 100mg vaginal ovule (product) Product containing precisely clindamycin (as clindamycin phosphate) 100 milligram/1 each conventional release vaginal pessary (clinical drug)
Clindamycin phosphate 10mg solution (product) Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution
Clindamycin phosphate 10mg/mL solution (product) Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution
Clindamycin phosphate 2% cream (product) Product containing precisely clindamycin phosphate 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug)
Clinical Outcomes in Routine Evaluation Outcome Measure Global Distress score (observable entity) Clinical Outcomes in Routine Evaluation Outcome Measure Global Distress total score
Clinical actions A - G (qualifier value) Action
Clinical actions A-O (qualifier value) Action
Clinical actions H - O (qualifier value) Action
Clinical actions P - S (qualifier value) Action
Clinical actions P-Z (qualifier value) Action
Clinical actions T - Z (qualifier value) Action
Clinical finding constatation clinique
Clinical management plan (qualifier value) Clinical management plan
Clinical stage 0 (finding) 0
Stage 0 0
Clinically relevant enzymes with no Enzyme Commission designation Enzyme
Clomocycline sodium adverse reaction Adverse reaction to clomocycline
Clonazepam 0.125mg wafer (product) Product containing precisely clonazepam 125 microgram/1 each conventional release orodispersible tablet (clinical drug)
Clonazepam 0.25mg wafer (product) Clonazepam 250 microgram orodispersible tablet
Clonazepam 0.5mg wafer (product) Clonazepam 500 microgram orodispersible tablet
Clonazepam 1mg wafer (product) Clonazepam 1 mg orodispersible tablet
Clonazepam 2mg wafer (product) Clonazepam 2 mg orodispersible tablet
Clopidogrel bisulfate 75mg tablet (product) Product containing precisely clopidogrel (as clopidogrel bisulfate) 75 milligram/1 each conventional release oral tablet (clinical drug)
Clorazepate dipotassium 7.5mg (product) Clorazepate dipotassium 7.5 mg oral tablet
luxation antérieure fermée de l'humérus luxation antérieure fermée de l'articulation glénohumérale (trouble)
Closed fracture finger metacarpal shaft fracture fermée de la diaphyse d'un os métacarpien (trouble)
Closed fracture of C1-C4 level with other specified spinal cord injury Closed fracture of C1-C4 level with spinal cord injury
Closed fracture of C5-C7 level with other specified spinal cord injury (disorder) Closed fracture of C5-C7 level with spinal cord injury
Closed fracture of T1-T6 level with other specified spinal cord injury (disorder) Closed fracture of T1-T6 level with spinal cord injury
Closed fracture of T7-T12 level with other specified spinal cord injury Closed fracture of T7-T12 level with spinal cord injury
Closed fracture of base of skull with intracranial injury of other and unspecified nature Closed fracture of base of skull with intracranial injury
Closed fracture of base of skull with other and unspecified intracranial hemorrhage (disorder) Closed fracture of base of skull with intracranial hemorrhage
Closed fracture of coccyx with spinal cord lesion Closed fracture of coccyx
Closed fracture of sacrum and coccyx with other cauda equina injury (disorder) Closed fracture of sacrum AND/OR coccyx with cauda equina injury
Closed fracture of sacrum and coccyx with other spinal cord injury Closed fracture of coccyx
Closed fracture of sacrum with spinal cord lesion Closed fracture sacrum
Closed fracture of sacrum without spinal cord injury (disorder) Closed fracture sacrum
Closed fracture of unspecified bone of lower limb (disorder) fracture d'un membre inférieur (trouble)
Closed fracture of vault of skull with intracranial injury of other and unspecified nature Closed fracture vault of skull with intracranial injury
Closed fracture of vault of skull with other and unspecified intracranial hemorrhage Closed fracture of vault of skull with intracranial hemorrhage
Closed hindbrain contusion Contusion of hindbrain
Closed inferior dislocation of humerus Closed inferior dislocation of glenohumeral joint (disorder)
Closed posterior dislocation of humerus Closed posterior dislocation of glenohumeral joint (disorder)
Closed reduction and application of cast or splint (procedure) Closed reduction of fracture AND application of cast (procedure)
Closed reduction of vertebral process fracture (procedure) Closed reduction of fracture of vertebra
Closed skull fracture with intracranial injury of other and unspecified nature Closed skull fracture with intracranial injury
Closed skull fracture with other and unspecified intracranial hemorrhage Closed skull fracture with intracranial hemorrhage
Closet gay Gay
Clostridium absonum Clostridium sardiniense
Clostridium barkeri Eubacterium barkeri
Clostridium botulinum B toxin 5000u/mL injection solution 2mL ampule RimabotulinumtoxinB 5000 unit/mL solution for injection
Clostridium botulinum, type G Clostridium argentiense
Clostridium bryantii Syntrophospora bryantii
Clostridium durum Paenibacillus durus (organism)
Clostridium fervidus Caloramator fervidus
Clostridium hydroxybenzoicum (organism) Sedimentibacter hydroxybenzoicus (organism)
Clostridium laramiense Clostridium estertheticum subspecies laramiense (organism)
Clostridium orbiscindens Flavonifractor plautii (organism)
Clostridium pfennigii Oxobacter pfennigii (organism)
Clostridium quercicolum (organism) Dendrosporobacter quercicolus (organism)
Clostridium thermoaceticum Moorella thermoacetica
Clostridium thermoautotrophicum Moorella thermoautotrophica
Clostridium thermocopriae Thermoanaerobacter thermocopriae
Clostridium thermolacticum Clostridium stercorarium subspecies thermolacticum (organism)
Clostridium thermosaccarolyticum Thermoanaerobacterium thermosaccharolyticum
Clostridium thermosaccharolyticum Thermoanaerobacterium thermosaccharolyticum
Clostridium thermosulfurigenes Thermoanaerobacterium thermosulfurigenes
Clostridium villosum Filifactor villosus
Closure by clamp (procedure) clampage
Closure of artificial opening of small intestine Closure of stoma of small intestine
Closure of enterovesical fistula Repair of fistula involving bladder and intestine (procedure)
Closure of fistula Closure - action
Repair of ileorectal fistula Repair of ileorectal fistula
Clotrimazole 1% conventional release eye drops Clotrimazole only product in ocular dose form
Clotrimazole 1% preservative-free eye drops (product) Clotrimazole only product in ocular dose form
Clotrimazole 100mg suppository Product containing precisely clotrimazole 100 milligram/1 each conventional release vaginal tablet (clinical drug)
Clotrimazole 10mg tablet (product) Product containing precisely clotrimazole 10 milligram/1 each conventional release oromucosal lozenge (clinical drug)
Clotrimazole 2%+10% cream+applicator (product) Product containing only clotrimazole (medicinal product)
Clotrimazole 2%+10% cream+applicator (product) Product containing only clotrimazole (medicinal product)
Clotrimazole 200mg suppository Product containing precisely clotrimazole 200 milligram/1 each conventional release vaginal tablet (clinical drug)
Clotrimazole 200mg/1% suppository+cream (product) Product containing only clotrimazole (medicinal product)
Clotrimazole 500mg suppository Clotrimazole 500 mg vaginal tablet
Clotrimazole 500mg/2% pessary+cream (product) Product containing only clotrimazole (medicinal product)
Cloxacillin sodium 125mg/5mL oral solution (product) Product containing precisely cloxacillin (as cloxacillin sodium) 25 milligram/1 milliliter conventional release oral suspension (clinical drug)

Start Previous Page 20 of 132 Next End


Reference Sets

Canada French language reference set (foundation metadata concept)

Reference set descriptor

Back to Start